New hope against superbugs: experimental drug combo targets deadly hospital infections
NCT ID NCT07431307
First seen Feb 28, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study tests a new drug called BV100 combined with other antibiotics to treat serious hospital-acquired infections like pneumonia and bloodstream infections caused by a hard-to-treat bacteria (CRABC). About 120 adults will take part to see if the combo is safe and works better than current best treatments. The goal is to control the infection and reduce deaths.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD STREAM INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.